Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM
Drug Metabolism and Disposition · 2026-11 · 100443
DOI: 10.1016/j.dmd.2026.100443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-11. Verfasst von Zachary Enlo-Scott und 2 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Gefördert von: F. Hoffmann-La Roche Ltd.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- F. Hoffmann-La Roche Ltd
Zitieren
APA
Enlo-Scott, Z., Wittwer, M., & Keemink, J. (2026). Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM. Drug Metabolism and Disposition, 100443. https://doi.org/10.1016/j.dmd.2026.100443
Vancouver
Enlo-Scott Z, Wittwer M, Keemink J. Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM. Drug Metabolism and Disposition. 2026:100443. doi:10.1016/j.dmd.2026.100443
BibTeX
@article{EnloScott2026,
author = {Enlo-Scott, Zachary and Wittwer, Matthias and Keemink, Janneke},
title = {Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM},
journal = {Drug Metabolism and Disposition},
year = {2026},
pages = {100443},
doi = {10.1016/j.dmd.2026.100443}
}
EUVIMED